Sonja Zweegman - Concepedia

Author

Sonja Zweegman

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

Cyrille Touzeau, Fabrizio Pane, H. A. M. Sinnige, S Zweegman, S. ZWEEGMAN, S. Zweegman, Somlo, George, Sonja Zweegman, Zweegman S, Zweegman, S.

763

Publications

32.2K

Citations

H-Index

158

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Amsterdam University Medical Centers Erasmus MC Cancer Institute Erasmus MC

About

Sonja Zweegman is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	77	12.6K
2	Health Sciences	25	37	9.3K
3	Natural Sciences	3	3	204
4	Public Health	2	2	110
5	Nursing	1	1	21

Sonja Zweegman

235

Publications

24.4K

Citations

H-Index

Page 1

	Year	Citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, The Lancet Oncology Hematological MalignancyMedicineHematologyDiagnosisPathology	2014	4.7K
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study Philippe Moreau, Michel Attal, Cyrille Hulin, The Lancet Hematological MalignancyRadiation OncologyMedicineImmunologyHematology	2019	922
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Philippe Moreau, Jesús F. San Miguel, Pieter Sonneveld, Annals of Oncology Hematological MalignancyMedicineHematologyMyeloid NeoplasiaMultiple Myeloma	2017	847
Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt, Journal of Clinical Oncology	2012	819
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Meletios Α. Dimopoulos, Philippe Moreau, Evangelos Terpos, Annals of Oncology Hematological MalignancyOncologyHematologyMyeloid NeoplasiaMultiple Myeloma	2021	782
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Blood	2015	739
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Journal of Clinical Oncology	2012	441
The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells Anna van Rhenen, Guus A.M.S. van Dongen, Angèle Kelder, Blood	2007	424
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications Evangelos Terpos, Martina Kleber, Monika Engelhardt, Haematologica Bone DiseaseHematological MalignancyZoledronic AcidEuropean Myeloma NetworkMedicine	2015	391
Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement Meletios Α. Dimopoulos, Jens Hillengaß, Saad Z. Usmani, Journal of Clinical Oncology	2015	387

Page 1